References
- Paw Cho Sing E, Robinson P, Flank J, et al. Classification of the acute emetogenicity of chemotherapy in pediatric patients: a clinical practice guideline. Pediatr Blood Cancer. 2019;66:e27646.
- Dupuis LL, Boodhan S, Sung L, et al. Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients. Pediatr Blood Cancer. 2011;57(2):191–198. doi:10.1002/pbc.23114.
- National Comprehensive Cancer Institute. Antiemesis Guidelines (Version 1.2023). https://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf. Accessed March 31, 2023.
- Hesketh PJ, Kris MG, Basch E, et al. Antiemetics: ASCO guideline update. J Clin Oncol. 2020;38(24):2782–2797. doi:10.1200/JCO.20.01296.
- Steinherz PG, Redner A, Steinherz L, et al. Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse: The Memorial Sloan Kettering-New York-II Protocol. Blood. 1993;72(10):3120–3130.
- Patel P, Olteanu A, Cabral S, et al. Dexamethasone dosing for prevention of acute chemotherapy-induced vomiting in pediatric patients: a systematic review. Pediatr Blood Cancer. 2020;67(12):e28716.